User contributions
Jump to navigation
Jump to search
- 18:57, 29 January 2024 diff hist +44 Lenalidomide (Revlimid) →Toxicity management current
- 18:48, 29 January 2024 diff hist +1,416 Lenalidomide (Revlimid) →Toxicity management
- 17:35, 9 January 2024 diff hist +3,614 Multiple myeloma, induction →VTD-PACE {{#subobject:539ce9|Regimen=1}}
- 18:59, 10 August 2023 diff hist +1 Multiple myeloma, induction →Dara-RVd{{#subobject:5coba5|Regimen=1}}
- 16:03, 10 August 2023 diff hist +638 Multiple myeloma, induction →Synopsis
- 22:18, 8 August 2023 diff hist +1,956 Multiple myeloma, relapsed-refractory →Thalidomide monotherapy {{#subobject:ff02e1|Regimen=1}}
- 21:49, 8 August 2023 diff hist +3,033 Multiple myeloma, consolidation and maintenance →Melphalan, then auto HSCT {{#subobject:263542|Regimen=1}}
- 21:45, 8 August 2023 diff hist -2,975 Multiple myeloma, consolidation and maintenance →Bortezomib & Melphalan, then auto HSCT {{#subobject:9c28bc|Regimen=1}}
- 21:44, 8 August 2023 diff hist +2,976 Multiple myeloma, consolidation and maintenance →Bortezomib & Melphalan, then auto HSCT {{#subobject:9c28bc|Regimen=1}}
- 21:15, 8 August 2023 diff hist +1,925 Multiple myeloma, induction Tag: visualeditor-switched
- 22:52, 14 December 2020 diff hist +1 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:52, 14 December 2020 diff hist +118 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:51, 14 December 2020 diff hist 0 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:50, 14 December 2020 diff hist 0 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:49, 14 December 2020 diff hist 0 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:49, 14 December 2020 diff hist +2 Multiple myeloma, relapsed-refractory →KRD-PACE {{#subobject:0072na|Regimen=1}}
- 22:48, 14 December 2020 diff hist +3,649 Multiple myeloma, relapsed-refractory →Relapsed or refractory, non-randomized or retrospective data
- 19:37, 18 May 2018 diff hist -388 Multiple myeloma →Bortezomib-HyperCAD
- 19:36, 18 May 2018 diff hist +2,353 Multiple myeloma →Bortezomib-HyperCAD
- 19:31, 18 May 2018 diff hist +26 Multiple myeloma →Relapsed or refractory, non-randomized or retrospective data